| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/04/2002 | WO2002051437A1 Induction of tolerance |
| 07/04/2002 | WO2002051264A2 Nutritional composition with health promoting action containing oligo-saccharides |
| 07/04/2002 | WO2002051254A1 Method of sterilizing antibody-containing milk and products containing sterilized antibody-containing milk |
| 07/04/2002 | WO2002030351A3 Improvement of graft acceptance through manipulation of thymic regeneration |
| 07/04/2002 | WO2002030259A3 Disease prevention by reactivation of the thymus |
| 07/04/2002 | WO2002017917A8 Manzamines for treatment of drug resistant infection |
| 07/04/2002 | WO2001085974A3 Retroviral vectors comprising an enhanced 3' transcription termination structure |
| 07/04/2002 | WO2001077298A3 Human müllerian duct-derived epithelial cells and methods of isolation and uses thereof |
| 07/04/2002 | WO2001076507A3 Use of oxygen carriers to improve grafted cell survival in neural transplantation |
| 07/04/2002 | WO2001032841A9 Method of in vitro t cell differentiation of cd34+ progenitor cells |
| 07/04/2002 | WO2001032189A9 Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 07/04/2002 | WO2001025441A3 Tumour-specific vector for gene therapy |
| 07/04/2002 | WO2000022430A9 Neisseria genomic sequences and methods of their use |
| 07/04/2002 | US20020088019 Methods of and pharmaceutical compositions for improving implantation of embryos |
| 07/04/2002 | US20020086832 Immunosuppressing a human after allogenic cell, tissue or organ transplantation by administering a caspase-8 inhibitor |
| 07/04/2002 | US20020086411 Defective adenovirus for use in the treatment of tumors |
| 07/04/2002 | US20020086383 Cell expansion factor; for use in the treatment and prevention of graft rejection |
| 07/04/2002 | US20020086379 Human membrane-spanning proteins |
| 07/04/2002 | US20020086284 Determining sensitivity of a cell to reovirus infection; obtain cells, monitor ras protein signaling, consistent signaling indicates sensitivity to reovirus infection |
| 07/04/2002 | US20020086064 Extracting aliquot of blood from subject; treating aliquot of blood ex vivo with stressor selected from oxidizing agent, ultraviolet radiation and elevated temperature; administering treated aliquot to subject |
| 07/04/2002 | US20020086063 Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations |
| 07/04/2002 | US20020086031 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen |
| 07/04/2002 | US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds. |
| 07/04/2002 | US20020086019 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances |
| 07/04/2002 | US20020086005 Tolerizing allografts of pluripotent stem cells |
| 07/04/2002 | US20020086004 Especially wherein said angiogenic factor is an endothelial cell growth factor chosen from the FGF family of growth factors and the VEGF family of growth factors. |
| 07/04/2002 | US20020086003 Thymus reactivation, especially by administering hematopoietic stem cells |
| 07/04/2002 | US20020086002 Hematopoietic stem cell gene therapy |
| 07/04/2002 | US20020086001 Normalization of defective T cell responsiveness through manipulation of thymic regeneration |
| 07/04/2002 | US20020086000 Stimulation of thymus for vaccination development |
| 07/04/2002 | US20020085998 Breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, and T cells that are specific for cells expressing such polypeptides. |
| 07/04/2002 | US20020085997 Tumor cells at least some of which contain at least one MHC-I-haplotype of the patient on the cell surface, and which are charged with one or more peptides binding to the MHC-I molecule |
| 07/04/2002 | US20020085996 Can be administered before, at the same time as, or after the transplant. |
| 07/04/2002 | US20020085995 In vivo induction for enhanced function of isolated hepatocytes |
| 07/04/2002 | US20020085993 Antigens of the invention may be used as immunogens for vaccines or for the treatment of autoimmune diseases such as juvenile diabetes and multiple sclerosis. |
| 07/04/2002 | US20020084221 Method for precipitating red blood cells |
| 07/04/2002 | US20020084187 Using Gradiflow electrophoresis technology for macromolecule separation which utilises tangential flow across the membrane |
| 07/04/2002 | CA2847458A1 Defects in periaxin associated with myelinopathies |
| 07/04/2002 | CA2782510A1 Polypeptides |
| 07/04/2002 | CA2436501A1 Educated nk t cells and their uses in the treatment of immune-related disorders |
| 07/04/2002 | CA2432214A1 Gene involved in apoptosis regulation |
| 07/04/2002 | CA2431835A1 Induction of tolerance |
| 07/04/2002 | CA2399280A1 Defects in periaxin associated with myelinopathies |
| 07/03/2002 | EP1219705A1 Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
| 07/03/2002 | EP1218538A2 Cancer associated antigens and uses therefor |
| 07/03/2002 | EP1218528A1 Producer cell for the production of retroviral vectors |
| 07/03/2002 | EP1218527A2 Adenoviral vectors for treating disease |
| 07/03/2002 | EP1218521A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 07/03/2002 | EP1218518A1 Dna polymerase lambda and uses thereof |
| 07/03/2002 | EP1218515A2 Regulation with binding cassette transporter protein abc1 |
| 07/03/2002 | EP1218511A1 Antimicrobial compositions |
| 07/03/2002 | EP1218509A2 Fibroblast growth factor-like polypeptides |
| 07/03/2002 | EP1218498A1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 07/03/2002 | EP1218494A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 07/03/2002 | EP1218490A2 Bio-artificial substrate for the production of animal and, in particular, human tissues and organs |
| 07/03/2002 | EP1218489A2 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 07/03/2002 | EP1218487A2 Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells |
| 07/03/2002 | EP1218035A2 Rapid peg-modification of viral vectors |
| 07/03/2002 | EP1218028A1 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigenspecific t cell responses |
| 07/03/2002 | EP1218025A1 Use of mullerian inhibiting substance for treating excess androgen states |
| 07/03/2002 | EP1218022A2 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba |
| 07/03/2002 | EP1218019A2 Oncolytic virus |
| 07/03/2002 | EP1218017A2 Combination of a statin and ex-vivo treated blood for treating atherosclerosis |
| 07/03/2002 | EP1217963A1 Devices and methods for treating tissue |
| 07/03/2002 | EP1030690B1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype |
| 07/03/2002 | EP0680346B1 Method of increasing the concentration of nitric oxide in blood |
| 07/03/2002 | CN1357109A Removal of prions from blood, plasma and other liquids |
| 07/03/2002 | CN1357050A Adenoviral vectors for treating disease |
| 07/03/2002 | CN1357048A Enhanced prodrug activation |
| 07/03/2002 | CN1357039A Detachment surface |
| 07/03/2002 | CN1357038A Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions |
| 07/03/2002 | CN1356390A Human leukemia associated reverse transcription virus gene and its application |
| 07/03/2002 | CN1356141A Process for preparing injection liquid of brain protein hydrolyzate |
| 07/03/2002 | CN1356135A Chinese medicine for treating rheumatoid arthritis |
| 07/03/2002 | CN1356133A Plaster for treating cervical vertebra hyperplasia |
| 07/03/2002 | CN1356130A Medicine for treating bone fracture |
| 07/03/2002 | CN1356129A Chinese medicine for comprehensively conditioning functions of human body and its preparing process |
| 07/03/2002 | CN1356128A Chinese medicine for treating rheumatic and rheumatoid diseases |
| 07/03/2002 | CN1356126A Medicine for treating tuberculosis |
| 07/03/2002 | CN1356125A Medicine for treating tumor |
| 07/03/2002 | CN1356124A Medicine for treating hepatism |
| 07/03/2002 | CN1356123A Medicine for treating female acyesis |
| 07/03/2002 | CN1356109A Acne ointment and its preparing process |
| 07/03/2002 | CN1356107A Freezing-dried injection powder 'Katisu' and its preparing process |
| 07/03/2002 | CN1086953C Medical oil for treating burn and scald and its preparing process |
| 07/03/2002 | CN1086952C Chinese pure medicinal prepn. for treaitng cervix erosion and its preparing method |
| 07/03/2002 | CN1086951C Instant powder for common cold |
| 07/03/2002 | CN1086950C Medicine for treating soft tissue injury |
| 07/03/2002 | CN1086949C Chinese medicine for hepatitis B and its prepn. |
| 07/03/2002 | CN1086947C Chinese medicine prepn. for curing radically chronic tonsilitis and intractable laryngopharyngitis and its prepn. method |
| 07/03/2002 | CN1086946C Thrombus dissolving capsule |
| 07/02/2002 | US6415201 Process and system for management of batches of components of the haematopoietic system for deferred use |
| 07/02/2002 | US6413769 α(1,3) galactosyltransferase negative porcine cells |
| 07/02/2002 | US6413762 Viral nucleotide sequences |
| 07/02/2002 | US6413735 Method of screening for a modulator of angiogenesis |
| 07/02/2002 | US6413518 Immunologically significant herpes simplex virus antigens and methods for identifying and using same |
| 07/02/2002 | US6413511 Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide |
| 07/02/2002 | US6412492 Mixed chimerism and tolerance |
| 07/02/2002 | CA2335409C Apparatus and method for plasma preparation |
| 07/02/2002 | CA2223699C In ovo vaccination against coccidiosis |